Related Experiment Videos
Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis
Frank Bellivier1, Pauline Chaste, Alain Malafosse
1Service de Psychiatrie Adulte (Pr Rouillon), Hôpital Henri Mondor et Albert Chenevier, Assistance Publique-Hôpitaux de Paris, Créteil, France. bellivier@im3.inserm.fr
Summary
The tryptophan hydroxylase (TPH) gene A218C polymorphism is significantly associated with suicidal behavior. Meta-analysis indicates the A allele may increase suicidal behavior risk in a dose-dependent manner.
Area of Science:
- Neurogenetics
- Psychiatric Genetics
- Behavioral Genetics
Background:
- Serotonergic metabolism genes are key candidates for suicidal behavior research.
- The tryptophan hydroxylase (TPH) gene, crucial for serotonin synthesis, has yielded conflicting results in association studies.
- Heterogeneity in study design and TPH gene polymorphisms complicates interpretation.
Purpose of the Study:
- To perform a meta-analysis of published studies on the TPH gene A218C polymorphism and suicidal behavior.
- To identify sources of heterogeneity contributing to conflicting results.
- To clarify the association between TPH A218C and suicidal behavior risk.
Main Methods:
- Systematic literature search for TPH gene polymorphism and suicidal behavior association studies.
- Meta-analysis using fixed and random effect models on nine eligible studies.
- Heterogeneity analysis to identify outlier studies.
Main Results:
- A significant association was found between the TPH A218C polymorphism and suicidal behavior (OR=1.62).
- Heterogeneity analysis identified two studies deviating from the global effect.
- Post-removal of outlier studies, the significant association persisted.
- The A allele showed a dose-dependent effect on suicidal behavior risk.
Conclusions:
- The TPH A218C polymorphism is a significant genetic factor associated with suicidal behavior.
- Meta-analysis provides robust evidence despite previous conflicting findings.
- The A allele may confer an increased, dose-dependent risk for suicidal behavior.